−60.4
Cartesian Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
−31.6
FY23:
−51.2
FY24:
−23.7
FY25:
−73.9
Change from FY21 to FY25
millions USD
FY21:
−17.1
FY22:
−15.0
FY23:
34.6
FY24:
−8.74
FY25:
−5.45
Change from FY21 to FY25
millions USD
FY21:
52.9
FY22:
39.2
FY23:
−13.1
FY24:
168
FY25:
−8.06
millions USD
FY21:
−24.6
FY22:
−7.40
FY23:
−29.8
FY24:
136
FY25:
−87.4
(positive)
Change from FY21 to FY25
millions USD
FY21:
−61.5
FY22:
−32.8
FY23:
−51.4
FY24:
−32.8
FY25:
−79.4
All amounts in millions USD